Abfero Pharmaceuticals, Inc. — Form D
Abfero Pharmaceuticals, Inc. of LEXINGTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-06-24. The offering totals $2.0M, of which $680K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-06-24
- Form: D
- Accession: 0001769029-20-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $680K
- Remaining: $1.3M
- Minimum investment: $30K
- Investors: 4
- Date of first sale: 2020-06-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-369580
Issuer
- Name: Abfero Pharmaceuticals, Inc.
- CIK: 0001769029
- Entity type: Corporation
- Jurisdiction: MASSACHUSETTS
- Incorporated: 2016
- Address: 405 WALTHAM STREET SUITE 353, LEXINGTON, MA, 02421
- Phone: 7812667297
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Michael X Penington | Director | Boston, MA |
| Thomas X Neenan | Director | Boston, MA |
| Thomas X Neenan | Executive Officer | Boston, MA |
| Steven X Burke | Director | Boston, MA |
| Steven X Burke | Executive Officer | Boston, MA |
| Thomas X. Neenan | Related Person | Lexington, MA |
| Steven Burke | Related Person | Lexington, MA |
| Michael Penington | Related Person | Lexington, MA |
Other filings by this issuer (3)
More